SOPHERA

Serial Number 77601152
606

Registration Progress

Application Filed
Oct 27, 2008
Under Examination
Jun 9, 2009
Approved for Publication
Feb 25, 2009
Published for Opposition
Mar 17, 2009
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SOPHERA
Previous Owner: GENENTECH, INC.
Classes: 005

Trademark Image

SOPHERA

Basic Information

Serial Number
77601152
Filing Date
October 27, 2008
Published for Opposition
March 17, 2009
Abandonment Date
July 12, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 12, 2010
Classes
005

Rights Holder

GENENTECH, INC.

03
Address
1 DNA WAY
SOUTH SAN FRANCISCO, CA 94080

Ownership History

GENENTECH, INC.

Original Applicant
03
SOUTH SAN FRANCISCO, CA

GENENTECH, INC.

Owner at Publication
03
SOUTH SAN FRANCISCO, CA

Legal Representation

Attorney
Allyn Taylor, Esq.

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

14 events
Date Code Type Description Documents
Jul 12, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jul 12, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 22, 2010 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 8, 2009 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 22, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 8, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 9, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 17, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 25, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Feb 7, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 7, 2009 ALIE A ASSIGNED TO LIE Loading...
Jan 28, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 28, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 30, 2008 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005